Differences in the Antinociceptive Effects and Binding Properties of Propranolol and Bupranolol Enantiomers

The S enantiomer of bupranolol, a β-receptor antagonist, shows greater antinociceptive efficacy and a superior preclinical safety profile and it should be considered as a unique β-adrenergic receptor compound to advance future clinical pain studies.